Ikarian Capital, LLC Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$520.6B

Holdings

114

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (114 positions)

#StockSharesValue% PortfolioType
101
JSPRJASPER THERAPEUTICS INC
25,107$139.3M0.03%
102
KPTIKARYOPHARM THERAPEUTICS INC
27,257$117.5M0.02%
103
MGNXMACROGENICS INC
80,071$96.9M0.02%
104
SGMTSAGIMET BIOSCIENCES INC
11,984$91.3M0.02%
105
AIRSAIRSCULPT TECHNOLOGIES INC
17,951$86.7M0.02%
106
SPRBSPRUCE BIOSCIENCES INC
1,000,000$72.5M0.01%
107
TKNOALPHA TEKNOVA INC
14,008$68.8M0.01%
108
HOOKHOOKIPA PHARMA INC
52,996$66.5M0.01%
109
TOVXTHERIVA BIOLOGICS INC
120,031$52.1M0.01%
110
TRAWTRAWS PHARMA INC
28,493$42.2M0.01%
111
AMIXAUTONOMIX MED INC
20,000$31.4M0.01%
112
SYBXSYNLOGIC INC
20,422$25.9M0.00%
113
RLMDRELMADA THERAPEUTICS INC
40,270$24.2M0.00%
114
NMRANEUMORA THERAPEUTICS INC.
12,498$9.2M0.00%
PreviousPage 2 of 2